Filters: author is de Lange [Clear All Filters]
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30. DOI
Mechanism-based pharmacodynamic modeling of S(-)-atenolol: estimation of in vivo affinity for the beta1-adrenoceptor with an agonist-antagonist interaction model,
J Pharmacol Exp Ther, vol. 324, no. 3, pp. 1234-42. DOI
Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics,
Eur J Pharm Sci, vol. 34, no. 2-3, pp. 149-63. DOI
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research,
Trends Pharmacol Sci, vol. 29, no. 4, pp. 186-91. DOI
- 2007
Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint,
Br J Pharmacol, vol. 151, no. 3, pp. 356-66. DOI
Reproducible and time-dependent modification of serum protein binding in Wistar Kyoto rats,
J Pharmacol Toxicol Methods, vol. 56, no. 1, pp. 72-8. DOI
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG,
Br J Pharmacol, vol. 151, no. 5, pp. 713-20. DOI
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux,
Br J Pharmacol, vol. 151, no. 5, pp. 701-12. DOI
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis,
Annu Rev Pharmacol Toxicol, vol. 47, pp. 357-400. DOI
- 2002
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain,
Clin Pharmacokinet, vol. 41, no. 10, pp. 691-703. DOI
- 1997
Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier,
Brain Res Brain Res Rev, vol. 25, no. 1, pp. 27-49. DOI
- 1995
Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain,
Br J Pharmacol, vol. 116, no. 5, pp. 2538-44.
The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics,
Pharm Res, vol. 12, no. 1, pp. 129-33.
Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeability,
Brain Res, vol. 702, no. 1-2, pp. 261-5. DOI
The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain,
Pharm Res, vol. 12, no. 12, pp. 1924-31.
- 1994
Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain,
Brain Res, vol. 666, no. 1, pp. 1-8.
- 1993
The use of intracerebral microdialysis to study blood-brain barrier transport in health, after modification and in disease,
Adv Exp Med Biol, vol. 331, pp. 257-62.


